Sutro Biopharma STRO
NASDAQ STRO
$16.11 +0.01 (+0.06%)
At close: Sep 30, 2026 · 4:00 PM EDT

Sutro Biopharma (STRO) Non Operating Interest Expenses (2017 - 2022)

Updated

Sutro Biopharma (STRO) posted Non Operating Interest Expenses of $2.79 million for Q3 2022, up 240.0% from $820,000 a year earlier and up 369.4% from the prior quarter.

Analysis

Sutro Biopharma (STRO) Non Operating Interest Expenses (2017 - 2022) Analysis & Trends

For the trailing twelve months through Sep 30, 2022, Non Operating Interest Expenses at Sutro Biopharma was $4.65 million; for FY2021, it came in at $3.14 million, down 23.1% from FY2020.

  • Annual Non Operating Interest Expenses shows a four-year compound annual growth rate of 50.5% (FY2017 to FY2021).
  • In prior years, Sutro Biopharma's Non Operating Interest Expenses was $4.08 million in FY2020 (-6.3%), $4.35 million in FY2019, -$290,000 in FY2018 and $612,000 in FY2017.
  • The Q3 2022 figure stands as the highest quarterly Non Operating Interest Expenses since Q2 2020.
  • On a year-over-year basis, Non Operating Interest Expenses increased in 1 of the last six quarters, with growth averaging 5.3%.
  • The strongest year-over-year quarter for Non Operating Interest Expenses in the past five years was Q3 2022, with growth of 240.0%; the weakest was Q2 2021, with a decline of 71.3%.
  • According to Business Quant data, Non Operating Interest Expenses for the three prior quarters was $594,000 (Q2 2022), $657,000 (Q1 2022) and $612,000 (Q4 2021).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Operating Interest Expenses (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 281.00 Mn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -462.00 Mn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -435.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 673.00 Mn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 247.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Sutro Biopharma 267.04 Mn -411.46 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2022 2.79 Mn
Jun 30, 2022 594,000.00
Mar 31, 2022 657,000.00
Dec 31, 2021 612,000.00
Sep 30, 2021 820,000.00
Jun 30, 2021 847,000.00
Mar 31, 2021 858,000.00
Dec 31, 2020 -2.25 Mn
Sep 30, 2020 2.32 Mn
Jun 30, 2020 2.96 Mn
Mar 31, 2020 1.06 Mn
Dec 31, 2019 817,000.00
Sep 30, 2019 1.14 Mn
Jun 30, 2019 1.23 Mn
Mar 31, 2019 1.16 Mn
Dec 31, 2018 -649,000.00
Sep 30, 2018 483,000.00
Jun 30, 2018 -507,000.00
Mar 31, 2018 383,000.00
Dec 31, 2017 377,000.00
API Access

Sutro Biopharma Non Operating Interest Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=STRO&period=max&api_key=YOUR_API_KEY